KEGG   PATHWAY: fca04610
Entry
fca04610                    Pathway                                
Name
Complement and coagulation cascades - Felis catus (domestic cat)
Description
The complement system is a proteolytic cascade in blood plasma and a mediator of innate immunity, a nonspecific defense mechanism against pathogens. There are three pathways of complement activation: the classical pathway, the lectin pathway, and the alternative pathway. All of these pathways generate a crucial enzymatic activity that, in turn, generates the effector molecules of complement. The main consequences of complement activation are the opsonization of pathogens, the recruitment of inflammatory and immunocompetent cells, and the direct killing of pathogens. Blood coagulation is another series of proenzyme-to-serine protease conversions, culminating the formation of thrombin, the enzyme responsible for the conversion of soluble fibrinogen to the insoluble fibrin clot. Protease-activated receptors, such as those activated by thrombin, are members of G protein-coupled receptors and function as a mediator of innate immunity. The kallikrein-kinin system is an endogenous metabolic cascade, triggering of which results in the release of vasoactive kinins (bradykinin-related peptides). Kinin peptides are implicated in many physiological and pathological processes including the regulation of blood pressure and sodium homeostasis, inflammatory processes, and the cardioprotective effects of preconditioning.
Class
Organismal Systems; Immune system
Pathway map
fca04610  Complement and coagulation cascades
fca04610

Organism
Felis catus (domestic cat) [GN:fca]
Gene
100049012  THBD; thrombomodulin [KO:K03907]
100127105  SERPINE1; plasminogen activator inhibitor 1 [KO:K03982]
100313488  F12; coagulation factor XII precursor [KO:K01328] [EC:3.4.21.38]
101080460  A2M; alpha-2-macroglobulin [KO:K03910]
101080534  F13A1; coagulation factor XIII A chain isoform X2 [KO:K03917] [EC:2.3.2.13]
101080897  [KO:K03984]
101081027  F2RL3; proteinase-activated receptor 4 isoform X1 [KO:K04236]
101081119  VSIG4; V-set and immunoglobulin domain-containing protein 4 isoform X1 [KO:K19822]
101081903  SERPINA5; plasma serine protease inhibitor isoform X2 [KO:K03913]
101082116  CPB2; carboxypeptidase B2 [KO:K01300] [EC:3.4.17.20]
101082330  F3; tissue factor [KO:K03901]
101082667  [KO:K03916]
101082897  PROCR; endothelial protein C receptor [KO:K06557]
101084306  SERPINE2; glia-derived nexin [KO:K16643]
101085264  F5; coagulation factor V [KO:K03902]
101085412  SERPINB2; plasminogen activator inhibitor 2 [KO:K19821]
101085428  [KO:K23815]
101085823  PROS1; vitamin K-dependent protein S isoform X2 [KO:K03908]
101085836  SERPIND1; heparin cofactor 2 [KO:K03912]
101086649  CFI; complement factor I isoform X1 [KO:K01333] [EC:3.4.21.45]
101087258  ITGB2; integrin beta-2 [KO:K06464]
101087683  SERPING1; plasma protease C1 inhibitor [KO:K04001]
101087698  ITGAX; integrin alpha-X [KO:K06462]
101087957  ITGAM; integrin alpha-M isoform X1 [KO:K06461]
101088220  [KO:K03990]
101088468  [KO:K03990]
101088676  C1S; complement C1s subcomponent [KO:K01331] [EC:3.4.21.42]
101088940  C1R; complement C1r subcomponent isoform X1 [KO:K01330] [EC:3.4.21.41]
101089505  [KO:K04004]
101090401  C5; complement C5 isoform X1 [KO:K03994]
101090463  F2; prothrombin [KO:K01313] [EC:3.4.21.5]
101090581  F7; coagulation factor VII [KO:K01320] [EC:3.4.21.21]
101091240  PLAUR; urokinase plasminogen activator surface receptor isoform X1 [KO:K03985]
101091337  CFHR5; complement factor H-related protein 5 [KO:K23817]
101091588  F13B; coagulation factor XIII B chain isoform X1 [KO:K03906]
101092210  CD59; CD59 glycoprotein [KO:K04008]
101092434  C2; complement C2 isoform X3 [KO:K01332] [EC:3.4.21.43]
101092680  FGG; fibrinogen gamma chain [KO:K03905]
101092751  F8; coagulation factor VIII isoform X1 [KO:K03899]
101092846  CLU; clusterin [KO:K17252]
101092934  FGA; fibrinogen alpha chain [KO:K03903]
101093018  CFB; complement factor B [KO:K01335] [EC:3.4.21.47]
101093500  CFD; complement factor D [KO:K01334] [EC:3.4.21.46]
101093983  SERPINC1; antithrombin-III [KO:K03911]
101094092  KLKB1; plasma kallikrein isoform X3 [KO:K01324] [EC:3.4.21.34]
101094152  [KO:K04007]
101094340  F11; coagulation factor XI isoform X1 [KO:K01323] [EC:3.4.21.27]
101094346  [KO:K03989]
101094393  CR2; complement receptor type 2 isoform X1 [KO:K04012]
101094482  C7; complement component C7 isoform X2 [KO:K03996]
101094644  CD55; complement decay-accelerating factor isoform X1 [KO:K04006]
101094773  C1QC; complement C1q subcomponent subunit C [KO:K03988]
101094897  [KO:K04002]
101095148  C4BPB; C4b-binding protein beta chain isoform X1 [KO:K04003]
101095155  C6; LOW QUALITY PROTEIN: complement component C6 [KO:K03995]
101095261  PLG; plasminogen [KO:K01315] [EC:3.4.21.7]
101096082  C1QA; complement C1q subcomponent subunit A [KO:K03986]
101096161  PROC; vitamin K-dependent protein C isoform X4 [KO:K01344] [EC:3.4.21.69]
101096331  C1QB; complement C1q subcomponent subunit B [KO:K03987]
101096500  C8A; complement component C8 alpha chain [KO:K03997]
101096948  C9; complement component C9 [KO:K04000]
101097166  MASP1; mannan-binding lectin serine protease 1 isoform X1 [KO:K03992] [EC:3.4.21.-]
101098029  F10; coagulation factor X [KO:K01314] [EC:3.4.21.6]
101098338  PLAU; urokinase-type plasminogen activator [KO:K01348] [EC:3.4.21.73]
101098593  C5AR1; C5a anaphylatoxin chemotactic receptor 1 isoform X1 [KO:K04010]
101098813  TFPI; tissue factor pathway inhibitor [KO:K03909]
101098834  C8G; complement component C8 gamma chain isoform X2 [KO:K03999]
101099143  KNG1; kininogen-1 isoform X1 [KO:K03898]
101099229  C8B; complement component C8 beta chain isoform X1 [KO:K03998]
101099383  C3AR1; C3a anaphylatoxin chemotactic receptor [KO:K04009]
101099568  MASP2; mannan-binding lectin serine protease 2 isoform X1 [KO:K03993] [EC:3.4.21.104]
101099632  FGB; fibrinogen beta chain [KO:K03904]
101100166  SERPINF2; alpha-2-antiplasmin isoform X2 [KO:K03983]
101100299  PLAT; tissue-type plasminogen activator [KO:K01343] [EC:3.4.21.68]
101100615  F2RL2; proteinase-activated receptor 3 isoform X2 [KO:K04235]
101100765  VTN; vitronectin [KO:K06251]
101100840  MBL2; mannose-binding protein C [KO:K03991]
101100861  F2R; LOW QUALITY PROTEIN: proteinase-activated receptor 1 [KO:K03914]
102899273  [KO:K04007]
102899461  CR1L; complement component receptor 1-like protein isoform X2 [KO:K04011]
102900754  [KO:K04004]
111557813  [KO:K03990]
123382726  [KO:K04004]
493760  VWF; von Willebrand factor precursor [KO:K03900]
493973  F9; coagulation factor IX precursor [KO:K01321] [EC:3.4.21.22]
Compound
C00290  Fibrin
C00306  Bradykinin
C00471  Plasmin
C00752  Thrombin
C01065  Coagulation factor Xa
C01715  Plasma kallikrein
C02002  C3a anaphylatoxin
C03259  Coagulation factor IXa
C03262  Coagulation factor XIa
C03378  Coagulation factor VIIa
C03379  Coagulation factor XIIa
C03780  Coagulation factor Va
C04001  Coagulation factor VIIIa
C16510  C5a anaphylatoxin
C22531  Complement component 2a
C22532  Complement component 2b
C22533  Complement component 3b
C22534  Complement component 3f
C22535  Complement iC3b
C22536  Complement component 3dg
C22537  Complement component 3c
C22538  Complement component 3d
C22539  Complement C3(H2O)
C22540  Complement factor Bb
C22541  Complement component 4a
C22542  Complement component 4b
C22543  Complement component 4c
C22544  Complement component 4d
C22545  Complement component 5b
C22546  Coagulation factor XIIIa
C22547  APC
Reference
  Authors
Bajic G, Degn SE, Thiel S, Andersen GR
  Title
Complement activation, regulation, and molecular basis for complement-related diseases.
  Journal
EMBO J 34:2735-57 (2015)
DOI:10.15252/embj.201591881
Reference
  Authors
Mathern DR, Heeger PS
  Title
Molecules Great and Small: The Complement System.
  Journal
Clin J Am Soc Nephrol 10:1636-50 (2015)
DOI:10.2215/CJN.06230614
Reference
  Authors
Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT
  Title
Complement System Part I - Molecular Mechanisms of Activation and Regulation.
  Journal
Front Immunol 6:262 (2015)
DOI:10.3389/fimmu.2015.00262
Reference
  Authors
Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD
  Title
Interactions between coagulation and complement--their role in inflammation.
  Journal
Semin Immunopathol 34:151-65 (2012)
DOI:10.1007/s00281-011-0280-x
Reference
  Authors
Kurosawa S, Stearns-Kurosawa DJ
  Title
Complement, thrombotic microangiopathy and disseminated intravascular coagulation.
  Journal
J Intensive Care 2:65 (2014)
DOI:10.1186/s40560-014-0061-4
Reference
  Authors
Hillmeister P, Persson PB
  Title
The Kallikrein-Kinin system.
  Journal
Acta Physiol (Oxf) 206:215-9 (2012)
DOI:10.1111/apha.12007
Reference
  Authors
Rau JC, Beaulieu LM, Huntington JA, Church FC
  Title
Serpins in thrombosis, hemostasis and fibrinolysis.
  Journal
J Thromb Haemost 5 Suppl 1:102-15 (2007)
DOI:10.1111/j.1538-7836.2007.02516.x
Reference
  Authors
Crooks MG, Hart SP
  Title
Coagulation and anticoagulation in idiopathic pulmonary fibrosis.
  Journal
Eur Respir Rev 24:392-9 (2015)
DOI:10.1183/16000617.00008414
Reference
  Authors
Christiaans SC, Wagener BM, Esmon CT, Pittet JF
  Title
Protein C and acute inflammation: a clinical and biological perspective.
  Journal
Am J Physiol Lung Cell Mol Physiol 305:L455-66 (2013)
DOI:10.1152/ajplung.00093.2013
Reference
  Authors
Alberelli MA, De Candia E
  Title
Functional role of protease activated receptors in vascular biology.
  Journal
Vascul Pharmacol 62:72-81 (2014)
DOI:10.1016/j.vph.2014.06.001
Reference
  Authors
Smith HW, Marshall CJ
  Title
Regulation of cell signalling by uPAR.
  Journal
Nat Rev Mol Cell Biol 11:23-36 (2010)
DOI:10.1038/nrm2821
Reference
  Authors
Ricklin D, Lambris JD
  Title
Complement in immune and inflammatory disorders: pathophysiological mechanisms.
  Journal
J Immunol 190:3831-8 (2013)
DOI:10.4049/jimmunol.1203487
Reference
  Authors
Ricklin D, Lambris JD
  Title
Complement in immune and inflammatory disorders: therapeutic interventions.
  Journal
J Immunol 190:3839-47 (2013)
DOI:10.4049/jimmunol.1203200
Reference
  Authors
Loof TG, Deicke C, Medina E
  Title
The role of coagulation/fibrinolysis during Streptococcus pyogenes infection.
  Journal
Front Cell Infect Microbiol 4:128 (2014)
DOI:10.3389/fcimb.2014.00128
Reference
  Authors
Jozsi M, Tortajada A, Uzonyi B, Goicoechea de Jorge E, Rodriguez de Cordoba S
  Title
Factor H-related proteins determine complement-activating surfaces.
  Journal
Trends Immunol 36:374-84 (2015)
DOI:10.1016/j.it.2015.04.008
Related
pathway
fca04611  Platelet activation
fca04662  B cell receptor signaling pathway
fca04750  Inflammatory mediator regulation of TRP channels
KO pathway
ko04610   

DBGET integrated database retrieval system